 | • レポートコード：MRC2-11QY11862 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はエンセソパシー治療のグローバル市場について調査・分析したレポートです。種類別（足底筋膜炎、強直性脊椎炎、脊椎関節症、腱板断裂、アキレス腱炎、その他）市場規模、用途別（子供、成人）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別エンセソパシー治療の競争状況、市場シェア ・世界のエンセソパシー治療市場：種類別市場規模 2015年-2020年（足底筋膜炎、強直性脊椎炎、脊椎関節症、腱板断裂、アキレス腱炎、その他） ・世界のエンセソパシー治療市場：種類別市場規模予測 2021年-2026年（足底筋膜炎、強直性脊椎炎、脊椎関節症、腱板断裂、アキレス腱炎、その他） ・世界のエンセソパシー治療市場：用途別市場規模 2015年-2020年（子供、成人） ・世界のエンセソパシー治療市場：用途別市場規模予測 2021年-2026年（子供、成人） ・北米のエンセソパシー治療市場分析：米国、カナダ ・ヨーロッパのエンセソパシー治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのエンセソパシー治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のエンセソパシー治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのエンセソパシー治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Accuray Incorporated、Boston Scientific、CR Bard、Eli Lilly、Janssen Biotech、Pfizer、Siemens、Varian Medical Systems、Ultragenyx Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Enthesopathy is derived from a combination of entheso means a specific structure within the musculoskeletal system and pathy means presence of pathology.
The demand for enthesopathy treatment is expected to upsurge owing to the increasing number of sports injury, rising number of population going for workouts for good fitness score and the growing number of pathological research and increasing number of product pipeline by industry players.
Market Analysis and Insights: Global Enthesopathy Treatment Market
The global Enthesopathy Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Enthesopathy Treatment Scope and Market Size
Enthesopathy Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Enthesopathy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Accuray Incorporated
Boston Scientific
CR Bard
Eli Lilly
Janssen Biotech
Pfizer
Siemens
Varian Medical Systems
Ultragenyx Pharmaceutical
Market segment by Type, the product can be split into
Plantar Fasciitis
Ankylosing Spondylitis
Spondyloarthropathy
Rotator-Cuff Syndrome
Achilles Tendonitis
Others
Market segment by Application, split into
Children
Adult
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Enthesopathy Treatment Revenue
1.4 Market by Type
1.4.1 Global Enthesopathy Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Plantar Fasciitis
1.4.3 Ankylosing Spondylitis
1.4.4 Spondyloarthropathy
1.4.5 Rotator-Cuff Syndrome
1.4.6 Achilles Tendonitis
1.4.7 Others
1.5 Market by Application
1.5.1 Global Enthesopathy Treatment Market Share by Application: 2020 VS 2026
1.5.2 Children
1.5.3 Adult
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Enthesopathy Treatment Market Perspective (2015-2026)
2.2 Global Enthesopathy Treatment Growth Trends by Regions
2.2.1 Enthesopathy Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Enthesopathy Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Enthesopathy Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Enthesopathy Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Enthesopathy Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Enthesopathy Treatment Players by Market Size
3.1.1 Global Top Enthesopathy Treatment Players by Revenue (2015-2020)
3.1.2 Global Enthesopathy Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Enthesopathy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Enthesopathy Treatment Market Concentration Ratio
3.2.1 Global Enthesopathy Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Enthesopathy Treatment Revenue in 2019
3.3 Enthesopathy Treatment Key Players Head office and Area Served
3.4 Key Players Enthesopathy Treatment Product Solution and Service
3.5 Date of Enter into Enthesopathy Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Enthesopathy Treatment Historic Market Size by Type (2015-2020)
4.2 Global Enthesopathy Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Enthesopathy Treatment Market Size by Application (2015-2020)
5.2 Global Enthesopathy Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Enthesopathy Treatment Market Size (2015-2020)
6.2 Enthesopathy Treatment Key Players in North America (2019-2020)
6.3 North America Enthesopathy Treatment Market Size by Type (2015-2020)
6.4 North America Enthesopathy Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Enthesopathy Treatment Market Size (2015-2020)
7.2 Enthesopathy Treatment Key Players in Europe (2019-2020)
7.3 Europe Enthesopathy Treatment Market Size by Type (2015-2020)
7.4 Europe Enthesopathy Treatment Market Size by Application (2015-2020)
8 China
8.1 China Enthesopathy Treatment Market Size (2015-2020)
8.2 Enthesopathy Treatment Key Players in China (2019-2020)
8.3 China Enthesopathy Treatment Market Size by Type (2015-2020)
8.4 China Enthesopathy Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Enthesopathy Treatment Market Size (2015-2020)
9.2 Enthesopathy Treatment Key Players in Japan (2019-2020)
9.3 Japan Enthesopathy Treatment Market Size by Type (2015-2020)
9.4 Japan Enthesopathy Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Enthesopathy Treatment Market Size (2015-2020)
10.2 Enthesopathy Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Enthesopathy Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Enthesopathy Treatment Market Size by Application (2015-2020)
11 India
11.1 India Enthesopathy Treatment Market Size (2015-2020)
11.2 Enthesopathy Treatment Key Players in India (2019-2020)
11.3 India Enthesopathy Treatment Market Size by Type (2015-2020)
11.4 India Enthesopathy Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Enthesopathy Treatment Market Size (2015-2020)
12.2 Enthesopathy Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Enthesopathy Treatment Market Size by Type (2015-2020)
12.4 Central & South America Enthesopathy Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Enthesopathy Treatment Introduction
13.1.4 Abbott Laboratories Revenue in Enthesopathy Treatment Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Accuray Incorporated
13.2.1 Accuray Incorporated Company Details
13.2.2 Accuray Incorporated Business Overview
13.2.3 Accuray Incorporated Enthesopathy Treatment Introduction
13.2.4 Accuray Incorporated Revenue in Enthesopathy Treatment Business (2015-2020)
13.2.5 Accuray Incorporated Recent Development
13.3 Boston Scientific
13.3.1 Boston Scientific Company Details
13.3.2 Boston Scientific Business Overview
13.3.3 Boston Scientific Enthesopathy Treatment Introduction
13.3.4 Boston Scientific Revenue in Enthesopathy Treatment Business (2015-2020)
13.3.5 Boston Scientific Recent Development
13.4 CR Bard
13.4.1 CR Bard Company Details
13.4.2 CR Bard Business Overview
13.4.3 CR Bard Enthesopathy Treatment Introduction
13.4.4 CR Bard Revenue in Enthesopathy Treatment Business (2015-2020)
13.4.5 CR Bard Recent Development
13.5 Eli Lilly
13.5.1 Eli Lilly Company Details
13.5.2 Eli Lilly Business Overview
13.5.3 Eli Lilly Enthesopathy Treatment Introduction
13.5.4 Eli Lilly Revenue in Enthesopathy Treatment Business (2015-2020)
13.5.5 Eli Lilly Recent Development
13.6 Janssen Biotech
13.6.1 Janssen Biotech Company Details
13.6.2 Janssen Biotech Business Overview
13.6.3 Janssen Biotech Enthesopathy Treatment Introduction
13.6.4 Janssen Biotech Revenue in Enthesopathy Treatment Business (2015-2020)
13.6.5 Janssen Biotech Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Enthesopathy Treatment Introduction
13.7.4 Pfizer Revenue in Enthesopathy Treatment Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Siemens
13.8.1 Siemens Company Details
13.8.2 Siemens Business Overview
13.8.3 Siemens Enthesopathy Treatment Introduction
13.8.4 Siemens Revenue in Enthesopathy Treatment Business (2015-2020)
13.8.5 Siemens Recent Development
13.9 Varian Medical Systems
13.9.1 Varian Medical Systems Company Details
13.9.2 Varian Medical Systems Business Overview
13.9.3 Varian Medical Systems Enthesopathy Treatment Introduction
13.9.4 Varian Medical Systems Revenue in Enthesopathy Treatment Business (2015-2020)
13.9.5 Varian Medical Systems Recent Development
13.10 Ultragenyx Pharmaceutical
13.10.1 Ultragenyx Pharmaceutical Company Details
13.10.2 Ultragenyx Pharmaceutical Business Overview
13.10.3 Ultragenyx Pharmaceutical Enthesopathy Treatment Introduction
13.10.4 Ultragenyx Pharmaceutical Revenue in Enthesopathy Treatment Business (2015-2020)
13.10.5 Ultragenyx Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Enthesopathy Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Enthesopathy Treatment Revenue
Table 3. Ranking of Global Top Enthesopathy Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Enthesopathy Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Plantar Fasciitis
Table 6. Key Players of Ankylosing Spondylitis
Table 7. Key Players of Spondyloarthropathy
Table 8. Key Players of Rotator-Cuff Syndrome
Table 9. Key Players of Achilles Tendonitis
Table 10. Key Players of Others
Table 11. Global Enthesopathy Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Enthesopathy Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Enthesopathy Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Enthesopathy Treatment Market Share by Regions (2015-2020)
Table 15. Global Enthesopathy Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Enthesopathy Treatment Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Enthesopathy Treatment Market Growth Strategy
Table 21. Main Points Interviewed from Key Enthesopathy Treatment Players
Table 22. Global Enthesopathy Treatment Revenue by Players (2015-2020) (Million US$)
Table 23. Global Enthesopathy Treatment Market Share by Players (2015-2020)
Table 24. Global Top Enthesopathy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enthesopathy Treatment as of 2019)
Table 25. Global Enthesopathy Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Enthesopathy Treatment Product Solution and Service
Table 28. Date of Enter into Enthesopathy Treatment Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Enthesopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 31. Global Enthesopathy Treatment Market Size Share by Type (2015-2020)
Table 32. Global Enthesopathy Treatment Revenue Market Share by Type (2021-2026)
Table 33. Global Enthesopathy Treatment Market Size Share by Application (2015-2020)
Table 34. Global Enthesopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 35. Global Enthesopathy Treatment Market Size Share by Application (2021-2026)
Table 36. North America Key Players Enthesopathy Treatment Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Enthesopathy Treatment Market Share (2019-2020)
Table 38. North America Enthesopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 39. North America Enthesopathy Treatment Market Share by Type (2015-2020)
Table 40. North America Enthesopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 41. North America Enthesopathy Treatment Market Share by Application (2015-2020)
Table 42. Europe Key Players Enthesopathy Treatment Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Enthesopathy Treatment Market Share (2019-2020)
Table 44. Europe Enthesopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Enthesopathy Treatment Market Share by Type (2015-2020)
Table 46. Europe Enthesopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Enthesopathy Treatment Market Share by Application (2015-2020)
Table 48. China Key Players Enthesopathy Treatment Revenue (2019-2020) (Million US$)
Table 49. China Key Players Enthesopathy Treatment Market Share (2019-2020)
Table 50. China Enthesopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 51. China Enthesopathy Treatment Market Share by Type (2015-2020)
Table 52. China Enthesopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 53. China Enthesopathy Treatment Market Share by Application (2015-2020)
Table 54. Japan Key Players Enthesopathy Treatment Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Enthesopathy Treatment Market Share (2019-2020)
Table 56. Japan Enthesopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Enthesopathy Treatment Market Share by Type (2015-2020)
Table 58. Japan Enthesopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Enthesopathy Treatment Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Enthesopathy Treatment Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Enthesopathy Treatment Market Share (2019-2020)
Table 62. Southeast Asia Enthesopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Enthesopathy Treatment Market Share by Type (2015-2020)
Table 64. Southeast Asia Enthesopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Enthesopathy Treatment Market Share by Application (2015-2020)
Table 66. India Key Players Enthesopathy Treatment Revenue (2019-2020) (Million US$)
Table 67. India Key Players Enthesopathy Treatment Market Share (2019-2020)
Table 68. India Enthesopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 69. India Enthesopathy Treatment Market Share by Type (2015-2020)
Table 70. India Enthesopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 71. India Enthesopathy Treatment Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Enthesopathy Treatment Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Enthesopathy Treatment Market Share (2019-2020)
Table 74. Central & South America Enthesopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Enthesopathy Treatment Market Share by Type (2015-2020)
Table 76. Central & South America Enthesopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Enthesopathy Treatment Market Share by Application (2015-2020)
Table 78. Abbott Laboratories Company Details
Table 79. Abbott Laboratories Business Overview
Table 80. Abbott Laboratories Product
Table 81. Abbott Laboratories Revenue in Enthesopathy Treatment Business (2015-2020) (Million US$)
Table 82. Abbott Laboratories Recent Development
Table 83. Accuray Incorporated Company Details
Table 84. Accuray Incorporated Business Overview
Table 85. Accuray Incorporated Product
Table 86. Accuray Incorporated Revenue in Enthesopathy Treatment Business (2015-2020) (Million US$)
Table 87. Accuray Incorporated Recent Development
Table 88. Boston Scientific Company Details
Table 89. Boston Scientific Business Overview
Table 90. Boston Scientific Product
Table 91. Boston Scientific Revenue in Enthesopathy Treatment Business (2015-2020) (Million US$)
Table 92. Boston Scientific Recent Development
Table 93. CR Bard Company Details
Table 94. CR Bard Business Overview
Table 95. CR Bard Product
Table 96. CR Bard Revenue in Enthesopathy Treatment Business (2015-2020) (Million US$)
Table 97. CR Bard Recent Development
Table 98. Eli Lilly Company Details
Table 99. Eli Lilly Business Overview
Table 100. Eli Lilly Product
Table 101. Eli Lilly Revenue in Enthesopathy Treatment Business (2015-2020) (Million US$)
Table 102. Eli Lilly Recent Development
Table 103. Janssen Biotech Company Details
Table 104. Janssen Biotech Business Overview
Table 105. Janssen Biotech Product
Table 106. Janssen Biotech Revenue in Enthesopathy Treatment Business (2015-2020) (Million US$)
Table 107. Janssen Biotech Recent Development
Table 108. Pfizer Company Details
Table 109. Pfizer Business Overview
Table 110. Pfizer Product
Table 111. Pfizer Revenue in Enthesopathy Treatment Business (2015-2020) (Million US$)
Table 112. Pfizer Recent Development
Table 113. Siemens Business Overview
Table 114. Siemens Product
Table 115. Siemens Company Details
Table 116. Siemens Revenue in Enthesopathy Treatment Business (2015-2020) (Million US$)
Table 117. Siemens Recent Development
Table 118. Varian Medical Systems Company Details
Table 119. Varian Medical Systems Business Overview
Table 120. Varian Medical Systems Product
Table 121. Varian Medical Systems Revenue in Enthesopathy Treatment Business (2015-2020) (Million US$)
Table 122. Varian Medical Systems Recent Development
Table 123. Ultragenyx Pharmaceutical Company Details
Table 124. Ultragenyx Pharmaceutical Business Overview
Table 125. Ultragenyx Pharmaceutical Product
Table 126. Ultragenyx Pharmaceutical Revenue in Enthesopathy Treatment Business (2015-2020) (Million US$)
Table 127. Ultragenyx Pharmaceutical Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Enthesopathy Treatment Market Share by Type: 2020 VS 2026
Figure 2. Plantar Fasciitis Features
Figure 3. Ankylosing Spondylitis Features
Figure 4. Spondyloarthropathy Features
Figure 5. Rotator-Cuff Syndrome Features
Figure 6. Achilles Tendonitis Features
Figure 7. Others Features
Figure 8. Global Enthesopathy Treatment Market Share by Application: 2020 VS 2026
Figure 9. Children Case Studies
Figure 10. Adult Case Studies
Figure 11. Enthesopathy Treatment Report Years Considered
Figure 12. Global Enthesopathy Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Enthesopathy Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Enthesopathy Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Enthesopathy Treatment Market Share by Players in 2019
Figure 17. Global Top Enthesopathy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enthesopathy Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Enthesopathy Treatment Revenue in 2019
Figure 19. North America Enthesopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Enthesopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Enthesopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Enthesopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Enthesopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Enthesopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Enthesopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
強直性脊椎炎治療の世界市場（～2026年） Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and p…- 強直性脊椎炎治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ankylosing Spondylitis Drug Market The global Ankylosing Spondylitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ankylosing Spondylitis Drug Scope and Market Size Ankylosin…
- ドラベ症候群治療の世界市場（～2026年） Dravet syndrome is a rare, severe form of intractable epilepsy. It occurs due to a mutation in the SCN1A gene, which is required for the proper function of brain cells. Although there is no cure for Dravet syndrome, most treatments aim to reduce seizures. First line anti-seizure medications include …
- バーター症候群治療の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. The global market for Bartter syndrome treatment is expected to witness a moderate growth rate over the forecast period. Market Analysis and Insights: Global Bartter Syndrome Treatment Market The global Bart…
- 多嚢胞性卵巣症候群治療の世界市場（～2026年） Polycystic ovary syndrome is a set of symptoms due to elevated androgens in females. Signs and symptoms of polycystic ovary syndrome nclude irregular or no menstrual periods, heavy periods, excess body and facial hair, acne, pelvic pain, difficulty getting pregnant and patches of thick, darker, velv…